WHO ICTRP trial
A Single-Center Exploratory Study to Evaluate the Safety and Efficacy of FKC289…
ChiCTR2500100410 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500100410 |
|---|---|
| Public title | A Single-Center Exploratory Study to Evaluate the Safety and Efficacy of FKC289 injection (autologous CAR-T cells with dual targeting of BCMA and CD19) in Subjects with Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis |
| Scientific title | A Single-Center Exploratory Study to Evaluate the Safety and Efficacy of FKC289 injection (autologous CAR-T cells with dual targeting of BCMA and CD19) in Subjects with Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis |
| Primary sponsor | ZhongShan Hospital Fudan University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis |
| Interventions | Single arm:FKC289 Injection |
| Registration date | Apr 9, 2025 |
| Target size | Single arm:9 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: